The inhibition of PARP1 by specific drugs and siRNA inhibits formation of PARP1/Ku80/Ku70 complexes, silences multiple pathways of liver cancer, and results in inhibition of proliferation of cancer cells. The gene discussed is XRCC5; the disease is liver cancer.